MedTrace Logo

Study to Determine if Administration of Sugammadex Impacts Hospital Efficiency

NCT02860507 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-04-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the efficacy of Sugammadex in rapidly reversing deep neuromuscular blockaded (induced by rocuronium)

Conditions

  • Neuromuscular Blockade

Interventions

DRUG

sugammadex

DRUG

Neostigmine

DRUG

Glycopyrrolate

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-02-28
Completion
2018-02-28

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02860507 on ClinicalTrials.gov